The Didi Chuxing, Tencent and Taikang Life-backed automotive sales services provider had originally targeted $300m and then $150m.
Month: July 2018
Samsung subscribes to Grover’s latest round
The pay-as-you go consumer product supplier has raised $14m in series A funding from investors including Samsung Next alongside more than $29m in debt.
Gengmei gets $50m in series D1 round
The cosmetic surgery services platform has collected $50m in a Meitu-backed round, its existing backers including Tencent, Fosun and CHJ.
Scandit canters to $30m series B
The computer vision technology provider has secured $30m in a GV-led round that included NGP Capital, bringing its total funding to $43m.
Agendia generates $35m
Athyrium Capital Management provided the capital for Debiopharm and Axa-backed breast cancer diagnostics system developer Agendia.
Liquidia licks IPO process to raise $50m
Biopharmaceutical company Liquidia Technologies, which counts PPD and Siemens as investors, floated in the middle of its range.
Editorial: Alphabet’s results highlights its ‘Other Bets’
With Facebook and Netflix stumbling without recognised corporate venturing units, it has been interesting to see the other big four US internet companies, Microsoft, Amazon, Alphabet and Apple, with powerful CVC investments report or predict strong results. Alphabet was the most clear-cut as it reported better-than-expected second-quarter earnings last Monday, driving Alphabet shares to a new… Continue reading Editorial: Alphabet’s results highlights its ‘Other Bets’
BP pumps $10m into Nio Capital
Corporate venturing fund Nio Capital has received a $10m commitment from BP following a partnership agreement in May.
Mesh Korea nets Hyundai as an investor
Hyundai has invested $20m in last-mile delivery service Mesh and an undisclosed sum in electric scooter developer Immotor.
Improbable attracts NetEase for $50m investment
NetEase has provided $50m for game development software producer Improbable in a deal that reportedly doubled its valuation to $2bn.
Lantern to shut off
The UPMC Enterprises-backed mental health tool provider had raised more than $21m but is shuttering after failing to secure an acquisition.
Sutro sucks in series E funding
Merck & Co, Celgene, Amgen and Eli Lilly all took part in an $85.4m round that boosted the cancer drug developer’s total funding to more than $175m.
Alexa Fund alerts second accelerator batch
Amazon’s corporate venturing unit has announced the nine artificial intelligence developers that will make up its second cohort.
Sanofi helps send $17m to Click Therapeutics
Click has secured financing in a round led by Sanofi Ventures as it develops digital medicines for conditions including depression, insomnia and chronic pain.